Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA's Bulks List: Section 503A Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through FDA Peptide Update: Category 2 Removals Explained Forward progress